Atlas Trials

A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries

Clinical trial NCT06539689 · RECRUITING

Trial details

NCT number
NCT06539689
Sponsor
FrontAce Scientific Co., Ltd
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Peripheral Arterial DiseaseStenosisDissection
Start date
2024-06-04
Primary completion
2026-12-04
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.